Online insurance provider Justos raised $35.8m in a SoftBank-led series A round while social game studio GreenPark Sports closed a $31m series B that included Alameda Research.

The RTL and Mediaocean-backed advertising technology provider increased its valuation to $1.4bn in a round which will help it increase staff numbers.

Takeda, Merck & Co, Ipsen and Merck Group all scored exits as the immuno-oncology drug developer floated at the bottom of its IPO range.

Blue Venture Fund and CVS Health Ventures helped the telemedicine system developer raise funding which will boost its expansion into new markets and expand its treatment offering.

The market communicationns platform developer is going public today in an $81m initial public offering which will enable OpenText to exit.

DraftKings was among the limited partners for the firm's oversubscribed debut fund, as were The Kraft Group, Madison Square Garden Sports and Madison Square Garden Entertainment.

Liberty Mutual, MS&AD Ventures and QBE Ventures all contributed to a series C round taking the climate risk analytics provider's total funding to at least $86m.

Leverage Health Solution, Cigna Ventures and Leaps by Bayer helped the skin condition treatment developer hike its total funding to approximately $67m.

Alexandria Venture Investments has supported the life science technology developer in its $88.9m series C round which has pushed total funding past $142m.

Osage University Partners has helped the UT Southwestern precision medicine spinout close a round which will be used to advance and expand its pipeline of respiratory disease drug candidates.